{"id":110046,"date":"2003-09-30T13:23:10","date_gmt":"2003-09-30T11:23:10","guid":{"rendered":"https:\/\/mediarun.com\/index.php\/news-posts\/rowland-communications-dla-glaxosmithkline-2\/"},"modified":"2003-09-30T13:23:10","modified_gmt":"2003-09-30T11:23:10","slug":"rowland-communications-dla-glaxosmithkline-2","status":"publish","type":"post","link":"https:\/\/mediarun.com\/pl\/marketing\/atl\/rowland-communications-dla-glaxosmithkline-2.html","title":{"rendered":"Rowland Communications dla GlaxoSmithKline"},"content":{"rendered":"<p>Zadaniem Rowland jest upowszechnienie informacji, \u017ce szczepionki dla najm\u0142odszych r\u00f3\u017cni\u0105 si\u0119 jako\u015bci\u0105, sk\u0142adem oraz sposobem podawania i \u017ce mo\u017cna dokonywa\u0107 pomi\u0119dzy<br \/>\nnimi wyboru. <\/p>\n<p>Akcja &#8222;Mamo, masz wyb\u00f3r&#8221; ma zwr\u00f3ci\u0107 uwag\u0119 na profity zwi\u0105zane z zastosowaniem nowoczesnych szczepionek skojarzonych, czyli preparat\u00f3w zabezpieczaj\u0105cych dziecko przed dwoma, trzema, a nawet pi\u0119cioma chorobami dzi\u0119ki<br \/>\njednemu wk\u0142uciu. <\/p>\n<p>Szczepionki skojarzone oszcz\u0119dzaj\u0105 dziecku b\u00f3lu i \u0142ez zmniejszaj\u0105c jednocze\u015bnie ryzyko dzia\u0142a\u0144 niepo\u017c\u0105danych. Wa\u017cn\u0105 cz\u0119\u015bci\u0105 kampanii s\u0105 dzia\u0142ania edukacyjne skierowane do rodzic\u00f3w oraz \u015brodowiska medycznego. <\/p>\n","protected":false},"excerpt":{"rendered":"Rowland Communications zosta\u0142a wybrana Preferowanym Dostawc\u0105 Us\u0142ug PR dla GlaxoSmithKline. Agencji powierzono realizacj\u0119 kampanii edukacyjnej pod has\u0142em `Mamo, masz wyb\u00f3r`, dotycz\u0105cej korzy\u015bci ze stosowania szczepionek skojarzonych.","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"footnotes":""},"categories":[9642],"tags":[],"class_list":{"0":"post-110046","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-atl","7":"cs-entry","8":"cs-video-wrap"},"_links":{"self":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/110046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/comments?post=110046"}],"version-history":[{"count":0,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/110046\/revisions"}],"wp:attachment":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media?parent=110046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/categories?post=110046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/tags?post=110046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}